supported by grants from the National Key R&D Program of China (No.2022YFC2703701 to Qiji Liu);the National Natural Science Foundation of China (No.82271901,32070586);the Shandong Provincial Natural Science Foundation,China (No.ZR2020MH086);Taishan Scholar Program of Shandong Province (tsqn202211318);NHC Key Laboratory of Birth Defects Prevention,China (No.ZD202101).
Triple-negative breast cancer(TNBC)is defined by the lack of estrogen receptor(ER),progesterone receptor,and amplified human epidermal growth factor receptor expression.TNBC accounts for~15%of all breast cancer cases ...
Shenzhen“Medical and Health Three Projects”Project Grant(SZZYSM 202106003);Shenzhen Bao’an District of Medical and Health Research Project(2023JD212);Shenzhen Bao’an District of Traditional Chinese Medicine Clinical Research Project(2023ZYYLCZX-12);Weifang Health Committee Scientific Research Project(wfwsjk-2023-140).
Objective:To explore the best endometrial preparation scheme of freeze-thawed embryo transfer(FET)for patients with thin endometrium with kidney deficiency and blood stasis by comparing the clinical outcomes of three ...
supported by the Russian Science Foundation(project No.24-15-00173,https://rscf.ru/project/24-15-00173/).
Aim:Resistance to hormonal and targeted therapies in breast cancer limits treatment efficacy.Epigenetic alterations,including changes mediated by DNA methyltransferases,play a key role in this process.Previously,we id...
Background: In Sudan, the common endocrine therapy tamoxifen is prescribed to HR-positive patients, which is associated with a variety of complications such as hot flashes, vaginal discharge, and vaginal dryness. Obje...
BACKGROUND Breast cancer(BC) remains a public health problem. Tamoxifen(TAM) resistance has caused great difficulties for treatment of BC patients. Eukaryotic translation initiation factor 4E binding protein 1(EIF4EBP...
Cancer remains to be one of the most severe sicknesses globally.Cases have kept rising over the years.Breast cancer(BC),which is among the leading types of cancers and predominantly affects women,is the second leading...
The National Key Research and Development Program of China(2016YFA0102100,2021YFA1100500);NSFC 81800533,81870430,81422009,81770560。
Nonalcoholic fatty liver disease (NAFLD) which is a leading cause of chronic liver diseases lacks effective treatment. Tamoxifen hasbeen proven to be the first-line chemotherapy for several solid tumors in clinics, ho...
Objective:This post-approval safety study assessed the efficacy and safety of exemestane after 2-3 years of tamoxifen treatment among postmenopausal women with estrogen receptor-positive(ER+)early breast cancer in Chi...
funded in part by grants 81771553(S.G.),82071623(S.G.),and 81871144(X.L.)from the National Science Foundation of China;an Excellence in Centers of Clinical Medicine grant(2017ZZ01016)from the Science and Technology Commission of Shanghai Municipality;Clinical Research Plan grant SHDC2020CR2062B from Shanghai Shenkang Center for Hospital Development.
Objective:Despite the fact that adenomyosis is a fairly common gynecological disorder,its pathogenesis remains elusive.Several theories on the pathogenesis of adenomyosis have been proposed,but none of them has been p...
Background:Tamoxifen is a non-steroidal oestrogen receptor modulator.It has strong anti-estrogenic activity on oestrogen receptor 2 in the breast tissue.It is the treatment of choice in breast cancer cases following s...